ResearcherHarvard UniversityNo recent work listed

Indu Khatri

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7993-1953; OpenAlex author ID A5032153099. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper

Papers 2

A Transcriptomics-Based Meta-Analysis Combined With Machine Learning Identifies a Secretory Biomarker Panel for Diagnosis of Pancreatic Adenocarcinoma. Co-author DOI 10.3389/fgene.2020.572284 ↗
Systems Biology Approach to Identify Novel Genomic Determinants for Pancreatic Cancer Pathogenesis. Co-author DOI 10.1038/s41598-018-36328-w ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Manoj Bhasin · 2 shared papers, 2019–2020 · strength 0.34
- Paper A Transcriptomics-Based Meta-Analysis Combined With Machine Learning Identifies a Secretory Biomarker Panel for Diagnos… DOI 10.3389/fgene.2020.572284 ↗
- Paper Systems Biology Approach to Identify Novel Genomic Determinants for Pancreatic Cancer Pathogenesis. DOI 10.1038/s41598-018-36328-w ↗
Koelina Ganguly · 1 shared paper, 2019 · strength 0.11
- Paper Systems Biology Approach to Identify Novel Genomic Determinants for Pancreatic Cancer Pathogenesis. DOI 10.1038/s41598-018-36328-w ↗
Joseph Carmicheal · 1 shared paper, 2019 · strength 0.11
- Paper Systems Biology Approach to Identify Novel Genomic Determinants for Pancreatic Cancer Pathogenesis. DOI 10.1038/s41598-018-36328-w ↗
Surinder K. Batra · 1 shared paper, 2019 · strength 0.11
- Paper Systems Biology Approach to Identify Novel Genomic Determinants for Pancreatic Cancer Pathogenesis. DOI 10.1038/s41598-018-36328-w ↗
Sukhwinder Kaur · 1 shared paper, 2019 · strength 0.11
- Paper Systems Biology Approach to Identify Novel Genomic Determinants for Pancreatic Cancer Pathogenesis. DOI 10.1038/s41598-018-36328-w ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.